The world’s first placebo-controlled clinical trial proves the successful application of cold plasma jet kINPen MED in diabetic foot ulcers: Reactivation and acceleration of wound healing confirmed

Chronic wounds resulting from diabetic foot syndrome heal significantly faster if the standard therapy is complemented with atmospheric cold plasma treatments. This has now been successfully proved by scientists in the first placebo-controlled, randomised and patient-blinded clinical trial. The study device used was the kINPen[®] MED plasmajet of neoplas med, a joint development with the Leibniz Institute for Plasma Science and Technology e. V. (INP). The study results have now been published in the Journal of the American Medical Association (JAMA Network Open).[1][ ]Diabetic foot ulcers (